Filing Details
- Accession Number:
- 0001415889-25-020011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-18 16:15:07
- Reporting Period:
- 2025-07-16
- Filing Date:
- 2025-07-18
- Accepted Time:
- 2025-07-18 16:15:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1727196 | Scholar Rock Holding Corp | SRRK | Biological Products, (No Disgnostic Substances) (2836) | 823750435 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1740266 | S. Jeffrey Flier | 301 Binney Street Cambridge MA 02142 | No | No | No | No |
Transaction Summary
Sold: | 11,136 shares | Avg. Price: $40.02 | Total Value: $445,688.33 |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-07-16 | 11,136 | $40.02 | 0 | No | 4 | S | Indirect | Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 24,070 | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Represents shares owned directly by The Jeffrey S. Flier Family Trust - 2014, for which the Reporting Person's spouse, Eleftheria Maratos-Flier, and Samuel C. Sichko are trustees. The Reporting Person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.
- Consists of 16,438 shares of common stock and 7,632 RSUs.